XWELL (XWEL) Moat Score: 3/10 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XWEL XWELL Inc XWEL
27 GF Score
Price $1.00
GF Value $0.86
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is XWELL Moat Score?

XWELL XWEL -3.85% 27 Moat Score is 3 as of Aug. 24, 2026. GuruFocus rates XWEL with a GF Score™ of 27/100 and a GF Value™ of $0.86 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, XWELL ranks better than 77.1% on this metric.

XWELL has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

XWELL has No Moat: XWELL Inc does not demonstrate significant market leadership or unique intellectual property. The company lacks strong brand strength, customer loyalty, and durable cost advantages, with no significant regulatory barriers or network effects.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes XWELL might have No Moat - Very weak/transient advantages.


XWELL  (NAS:XWEL) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

XWELL Moat Score Related Terms


XWEL vs MBAI, NDRA, BIAF: Moat Score Comparison

For the Diagnostics & Research subindustry, XWELL's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XWELL Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, XWELL's Moat Score distribution charts can be found below:

* The bar in red indicates where XWELL's Moat Score falls into.


XWEL
27GF Score
XWELL Inc XWEL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
XWELL (XWEL) has a Moat Score of 3 as of Aug. 24, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, XWELL ranks #49 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 22.9%.
Is XWELL's Moat Score too high?
XWELL's current Moat Score is 3. Based on the distribution chart, XWELL ranks #49 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, XWELL has a GF Score™ of 27/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does XWELL's Moat Score compare to MBAI and NDRA?
According to the Medical Diagnostics & Research industry distribution chart, XWELL ranks #49 out of 214 companies for Moat Score. This places XWELL in the top 23% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. XWELL's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XWELL stock overvalued right now?
Based on GuruFocus' analysis, XWELL (XWEL) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.86, compared to a current price of $1.00 — trading 16.3% above its estimated fair value. The current Moat Score is 3. XWELL's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For XWELL (XWEL), the current Moat Score is 3 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XWELL (XWEL) Overvalued in 2026?

Based on GuruFocus' analysis, XWELL stock appears to be overvalued. The current stock price of $1.00 is trading 16.3% above its estimated GF Value™ of $0.86. GuruFocus considers XWELL to be Modestly Overvalued.

Key valuation signals for XWEL:

  • Moat Score: 3
  • GF Value™: $0.86 vs. price of $1.00 (16.3% above fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the XWEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


XWELL Business Description

Address 254 West 31st Street, 11th Floor, New York, NY, USA, 10001
XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.
27GF Score

Get the complete analysis for XWEL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.00
Price
$0.86
GF Value